Read + Share
Amedeo Smart
Independent Medical Education
Rosenthal EM, Hall EW, Rosenberg ES, Harris A, et al. Assessing the cost-utility of preferentially administering Heplisav-B vaccine to certain populations. Vaccine 2020 Nov 4. pii: S0264-410X(20)31387.PMID: 33160756
Email
LinkedIn
Facebook
Twitter
Privacy Policy